Pfizer-sponsored study of "patients who are at standard risk for severe Covid-19 or who are fully vaccinated and have at least one risk factor for severe Covid-19" concludes that the efficacy of Pfizer's anti-Covid drug, Paxlovid, "has not been established."
Pfizer and a Corruption Too Deep to Fix | Epoch Times | Jeffrey A. Tucker:
April 8, 2024 - "[T]he COVID medication Paxlovid ... was approved under 'emergency use' in December 2021, and trumpeted by [Anthony] Fauci, President Biden, and the rest of the usual crowd. It was 90 percent effective, they said! The White House authorized $11 billion and more to pay for it, and dispatched the whole army of media mavens to push this thing. The White House was able to claim it was free, if you had insurance but even that would last only for so long. Eventually, the consumer had to pay and it was nearly $1,500 for 20 pills....
"Paxlovid was greeted with all the usual hosannas from the drug company as echoed by big media. The drug is 89 percent effective, they kept saying. The governments of Canada, the United States, and the UK all celebrated and showered Pfizer with multiple rounds of billions of dollars.
"But even from the outset, it seems there were many reports of rebounds. The drug would reduce symptoms for a few days even to the point of generating a negative test but then COVID would come back. This happened often enough that pharma skeptics grew deeply suspicious of it, especially because of such a very long run of patented failings in this realm....
"Biden, for example, seems to have gotten COVID four times after being treated repeatedly with Paxlovid. So too with Biden’s wife. The same happened with Fauci himself. Most every prominent person reported something similar. But that did not stop the gravy train from running, with the entire medical professional rallying around this drug.
"From the outset, The Epoch Times was reporting skeptically about it, the only media venue to do so. More and more doubts emerged, not in official circles but online in alternative media.
"Now we come to the kicker. Pfizer itself has finally published its randomized placebo-controlled trial of several hundred individuals with the Delta variant, which would have been two and a half years ago. The title of the results as published in the New England Journal of Medicine: 'Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.' Notice the absence of the word Paxlovid, making it all the more difficult for regular people to find. Nirmatrelvir is the clinical name.
"And the conclusion: 'Nirmatrelvir–ritonavir was not associated with a significantly shorter time to sustained alleviation of Covid-19 symptoms than placebo, and the usefulness of nirmatrelvir–ritonavir in patients who are not at high risk for severe Covid-19 has not been established.'
"In other words: this drug does not work. At all. It is no better than nothing. It is not useful. Countless billions later and this is what we have, a completely useless thing. At best....
"You will notice that you have not seen this reported in any mainstream media, even though it appears in the top medicine journal in the United States. That’s because the mainstream media is entirely in the pay of pharma. The conspiracy is out in the open, and all official channels are implicated. There seems to be zero accountability or appeal. It’s no wonder that RFK, Jr., is calling for racketeering investigations to be made against the whole industry and its industrial partners. This is aggressive robbery and fraud. Very few people even know to care because they are not being told the brutal facts of the case.
"One also wonders how it is that Pfizer held onto this study for two years before releasing it.
"Why would Pfizer choose just now to announce that its wonder drug is actually useless? My own theory: its accounting ledgers are showing that the drug’s period of high profitability is at an end. There’s no more high-margin profits associated with it. Might as well retire it. With a complicit legacy media, it has no egg on its face. It can just chalk up its wild Paxlovid push as profitable and done, like a seasonal beer or a pumpkin-spice latte. There is essentially no downside to moving onward to other products in its arsenal.
"But think about what this means for this company and for the system that protects it. What does this say about the vaccine? What does it mean for the whole network of protection, from regulators to journals to media? They are all in on the game. And how deep and wide is this game?"
Read more: https://www.theepochtimes.com/opinion/pfizer-and-a-corruption-too-deep-to-fix-5624319
Read study: https://www.nejm.org/doi/full/10.1056/NEJMoa2309003
Paxlovid does not lower risk of long-term COVID-19 symptoms, UCSF study shows | ABC7 News Bay Area | January 4, 2024:
No comments:
Post a Comment